Decoding India’s Regulatory Landscape

Carver Agents

Regulatory news, updates, and insights for India presented by the Carver Agents team

  1. 4d ago

    [India] Key Regulatory Updates on Investor Protection & Monographs

    This episode dives into recent regulatory developments affecting multiple sectors including pharmaceuticals, data protection, and financial markets. Listeners will gain insights into the Indian Pharmacopoeia Commission's draft revisions to monographs and general chapters, highlighting new microbial contamination limits and sterility standards for key drugs. The Ministry of Education and NCERT's ongoing workshops focus on the Digital Personal Data Protection Act, 2023, aiming to enhance understanding of consent and fiduciary obligations among officers. Additionally, SEBI has broadened refund eligibility for PACL investors and extended timelines for the e-auction of PACL properties in Cuttack and Pune, with updated payment schedules and property details. Investor caution regarding live trading strategies on social media is also emphasized, alongside updates on refunds for Citrus Check Inns Limited and Royal Twinkle Star Club Pvt. Ltd. For more information, visit the Carver Agents website. Articles mentioned: Address by Chairman at FICCI Capital Markets ConferenceAddress by Shri Tuhin Kanta Pandey, Chairman, SEBI “SEBI Symposium on Cyber Defence” Aug 17, 2026Address by Shri KVR Murty, WTM, SEBI at FICCI Capital Markets Conference48/2026 - 17.08.2026 - Caution to Investors regarding display of Live trading strategies on Social Media PlatformsDraft Revision - 18.08.2026 - IP Monographs/General Chapters for Comments25.08.2026 - DPDP Act Workshop for NCERT Officers03.09.2026 - DPDP Act Workshop for NCERT OfficersLTM / RANDSTAD (DIGITAL SOLUTIONS BUSINESS)Federal Reserve Board announces approval of application by National Westminster Bank PlcCancellation of the order of Appointment of Administrator in respect of Sahara India Life Insurance Company Limited

  2. Jun 29

    [India] Regulatory News: Trade Remedies & Amendments

    This episode delves into India's current regulatory landscape, focusing on key sectors such as Trade Remedy, pharmaceutical amendments, and international compliance frameworks. Major updates include the launch of multiple anti-dumping investigations by India’s Ministry of Commerce and Industry targeting imports like antioxidants, Resorcinol, nylon films, and sodium nitrite from countries including China, Japan, South Korea, and Thailand. These investigations mandate stakeholder submissions via official portals within 37 days. Another significant development is the Securities and Exchange Board of India’s proposal for a common advertisement code and the Integrated or Regulatory Sandbox framework (IoRS), designed to streamline testing of hybrid financial products under multiple regulators. Additionally, the Indian Pharmacopoeia Commission has issued amendment lists and errata for the 2026 edition, emphasizing biotechnology-derived therapeutics and vaccine monographs, urging stakeholders to adopt these updates. For more information, visit the Carver Agents website. Articles mentioned: 印度对涉华抗氧化剂启动反倾销调查印度对涉华间苯二酚启动反倾销调查印度对涉华双向拉伸尼龙薄膜启动反倾销调查印度对华亚硝酸钠启动反倾销调查印度对华装饰纸启动第一次反倾销日落复审调查Indian Pharmacopoeia 2026- Amendment ListsSudan-related Designations日・インド間の二国間クレジット制度(JCM)の実施規則(RoI : Rule of Implementation)を策定しました36/2026 - 23.06.2026 - SEBI Proposes Common Advertisement Code for Specified Regulated Entities印度对涉华合金和非合金热轧钢板启动反倾销调查

  3. Jun 22

    [India] Key Regulatory Updates on UK-India FTA & IoRS

    This episode delves into significant regulatory measures shaping India's financial and trade sectors, focusing on the Inter-operable Regulatory Sandbox (IoRS), the UK-India Free Trade Agreement (FTA), SEBI’s operational timelines, and policy-based loan initiatives. The UK-India FTA, set to come into force mid-July, promises tariff reductions across multiple sectors and introduces the Double Contributions Convention Agreement, extending social security benefits to UK nationals in India. Businesses are mandated to register with HMRC for origin declarations within 28 days of publication. SEBI’s launch of the IoRS enables innovators to test hybrid financial products under multiple regulators via a unified window, simplifying compliance across sectors. Entities must apply through the Coordination Group and adhere to cybersecurity and cloud adoption frameworks. Additionally, SEBI has prescribed detailed timelines for processing applications and investor grievance redressal, emphasizing accountability and efficiency. Further, collaboration among key Indian financial regulators facilitates cross-sectoral innovation testing under harmonized eligibility and fee structures, supporting a robust fintech ecosystem. For more information, visit the Carver Agents website. Articles mentioned: The countdown begins: UK-India FTA enters into force on July 15th32/2026 - 17.06.2026 - Transaction in Securities of Unlisted Public Limited Companies on various PlatformsSEBI BenchmarksRTI Act, 2005ADB approves $700 million loan to transform Pakistan's insurance sector

About

Regulatory news, updates, and insights for India presented by the Carver Agents team